Get started
Author

Natella Yurievna Rakhmanina

Observed names: N RAKHMANINA, N Rakhmanina, N. Rakhmanina, N.Y. Rakhmanina, NATELLA Y. RAKHMANINA, NY Rakhmanina, Natella Rakhmanina, Natella Y Rakhmanina, Natella Y. Rakhmanina, Rakhmanina, N, Rakhmanina, Natella, Rakhmanina,Natella
Observed institutions: University of Southern California, Universidad Complutense de Madrid, Elizabeth Glaser Pediatric AIDS Foundation, Children's Mercy Hospital, Children's National, Duke University, Georgetown University, George Washington University, Georgetown University Medical Center, Clinton Health Access Initiative, Hospital Universitario 12 De Octubre, Ministry of Health, University of Maryland, College Park, University of Missouri–Kansas City, University of Arkansas for Medical Sciences
ORCID: 0000-0002-2246-4581
Observed ORCID: 0000-0002-2246-4581
OpenAlex ID: A5085465326
Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2024 · Michael Horberg, Melanie Thompson, et al. · Clinical Infectious Diseases · 140
PDF
Efavirenz in the therapy of HIV infection
2009 · Natella Y Rakhmanina, John N van den Anker · Expert Opinion on Drug Metabolism & Toxicology · 133
Pharmacokinetics of Lopinavir/Ritonavir Crushed Versus Whole Tablets in Children
2011 · Brookie M. Best, Edmund V. Capparelli, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 101
Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit?
2024 · Benjamin M. Liu, Natella Y. Rakhmanina, et al. · Viruses · 84
Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection
2017 · Eva Caroline Ruria, Rose Masaba, et al. · AIDS · 75
Pharmacological research in pediatrics: From neonates to adolescents☆
2006 · N RAKHMANINA, J VANDENANKER · Advanced Drug Delivery Reviews · 74
Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC*
2016 · Amanda D. Castel, Mariah M. Kalmin, et al. · AIDS Care · 60
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list
2019 · Martina Penazzato, Claire L Townsend, et al. · The Lancet HIV · 53
PDF
A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration
2019 · Xiaomei I. Liu, Paul Schuette, et al. · The Journal of Pediatrics · 52
Infant Feeding for Persons Living With and at Risk for HIV in the United States: Clinical Report
2024 · Lisa Abuogi, Lawrence Noble, et al. · PEDIATRICS · 51
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir
2019 · Xiaomei I. Liu, Jeremiah D. Momper, et al. · The Journal of Clinical Pharmacology · 48
Evaluating adherence to medication in children and adolescents with HIV
2009 · M Khan, X Song, et al. · Archives of Disease in Childhood · 47
Therapeutic Drug Monitoring in Children with HIV/AIDS
2004 · Pieter L. A. Fraaij, Natella Rakhmanina, et al. · Therapeutic Drug Monitoring · 47
HIV Drug Resistance in Children and Adolescents: Always a Challenge?
2021 · Wei Li A. Koay, Judith Kose-Otieno, et al. · Current Epidemiology Reports · 46
PDF
P026: Week 24 data from a phase 3 clinical trial of E/C/F/TAF in HIV-positive adolescents
2015 · Jag Batra, Hilda Kizito, et al. · Journal of the International AIDS Society · 43
Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial
2016 · Aditya H Gaur, Hilda Kizito, et al. · The Lancet HIV · 41
Advancing the prevention and treatment of HIV in children: priorities for research and development
2022 · Martina Penazzato, Claire L Townsend, et al. · The Lancet HIV · 37
Adolescents and Young Adults: The Pediatrician’s Role in HIV Testing and Pre- and Postexposure HIV Prophylaxis
2021 · Katherine K Hsu, Natella Yurievna Rakhmanina · PEDIATRICS · 37
Pharmacokinetic Optimization of Antiretroviral Therapy in Children and Adolescents
2011 · Michael N. Neely, Natella Y. Rakhmanina · Clinical Pharmacokinetics · 37
Pharmacotherapy of perinatal HIV
2005 · Edmund Capparelli, Natella Rakhmanina, et al. · Seminars in Fetal and Neonatal Medicine · 37
CYP3A5, ABCB1, and SLCO1B1 Polymorphisms and Pharmacokinetics and Virologic Outcome of Lopinavir/Ritonavir in HIV-Infected Children
2011 · Natella Y Rakhmanina, Michael N Neely, et al. · Therapeutic Drug Monitoring · 36
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations
2017 · Martina Penazzato, Devasena Gnanashanmugam, et al. · Clinical Infectious Diseases · 35
PDF
Adolescents and young adults with HIV and unsuppressed viral load: where do we go from here?
2024 · Natella Rakhmanina, Caroline Foster, et al. · Current Opinion in HIV and AIDS · 34
Breastfeeding Among People With Human Immunodeficiency Virus in North America: A Multisite Study
2023 · Judy Levison, Jennifer McKinney, et al. · Clinical Infectious Diseases · 34
PDF
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review
2020 · Tom G Jacobs, Elin M Svensson, et al. · Journal of Antimicrobial Chemotherapy · 34
PDF
Works count: 176
Citation count: 2,777
H-index: 31
I10-index: 79
Year
Topic
Type